Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Pharmacology/Therapy

Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: Concurrent chemo-radiotherapy vs radiotherapy alone

American Journal of Obstetrics and Gynecology | Nov 10, 2019 Pharmacology/Therapy

¹⁸F-FDG PET/CT is an early predictor of pathologic tumor response and survival after preoperative radiochemotherapy with bevacizumab in high-risk locally advanced rectal cancer

The Journal of Nuclear Medicine | Nov 09, 2019 Pharmacology/Therapy

Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors

Lung Cancer | Nov 07, 2019 Pharmacology/Therapy

Advanced cutaneous squamous cell carcinoma: Real world data of patient profiles and treatment patterns

Journal of the European Academy of Dermatology and Venereology | Nov 07, 2019 Pharmacology/Therapy

A cohort study of breast cancer risk after 20 years of follow-up of women treated with fertility drugs

Cancer Epidemiology, Biomarkers & Prevention | Nov 06, 2019 Pharmacology/Therapy

Randomized trial of lenalidomide vs observation in smoldering multiple myeloma

Journal of Clinical Oncology | Nov 05, 2019 Pharmacology/Therapy

Updated survival data for a phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy in patients with locally advanced non-small cell lung cancer

The Oncologist | Nov 05, 2019 Pharmacology/Therapy

A phase 2 randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 vs OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study

Gynecologic Oncology | Nov 05, 2019 Pharmacology/Therapy

The role of PD-L1 expression as a predictive biomarker: An analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors

Journal for ImmunoTherapy of Cancer | Nov 05, 2019 Pharmacology/Therapy

Cost-effectiveness analysis of upfront SBRT for oligometastatic stage IV non–small cell lung cancer based on mutational status

American Journal of Clinical Oncology | Nov 04, 2019 Pharmacology/Therapy

« Prev 1 … 123 124 125 126 127 … 375 Next »

Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: Concurrent chemo-radiotherapy vs radiotherapy alone

¹⁸F-FDG PET/CT is an early predictor of pathologic tumor response and survival after preoperative radiochemotherapy with bevacizumab in high-risk locally advanced rectal cancer

Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors

Advanced cutaneous squamous cell carcinoma: Real world data of patient profiles and treatment patterns

A cohort study of breast cancer risk after 20 years of follow-up of women treated with fertility drugs

Randomized trial of lenalidomide vs observation in smoldering multiple myeloma

Updated survival data for a phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy in patients with locally advanced non-small cell lung cancer

A phase 2 randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 vs OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study

The role of PD-L1 expression as a predictive biomarker: An analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors

Cost-effectiveness analysis of upfront SBRT for oligometastatic stage IV non–small cell lung cancer based on mutational status

Article: TSH Abnormalities and Treatment Algorithms in Primary Care

MD Clip on Diabetes & Urinary ACR: Detecting Kidney Damage Early with Dr Saraogi

Article: A Review on Fluoride Effects on Thyroid Function

Article: How to Diagnose and Differentiate Common Causes of Sudden Vision Loss

Eating ultra processed foods may speed up early signs of Parkinson's disease

Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: Concurrent chemo-radiotherapy vs radiotherapy alone

18F-FDG PET/CT is an early predictor of pathologic tumor response and survival after preoperative radiochemotherapy with bevacizumab in high-risk locally advanced rectal cancer

Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors

Advanced cutaneous squamous cell carcinoma: Real world data of patient profiles and treatment patterns

A cohort study of breast cancer risk after 20 years of follow-up of women treated with fertility drugs

Randomized trial of lenalidomide vs observation in smoldering multiple myeloma

Updated survival data for a phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy in patients with locally advanced non-small cell lung cancer

A phase 2 randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 vs OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study

The role of PD-L1 expression as a predictive biomarker: An analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors

Cost-effectiveness analysis of upfront SBRT for oligometastatic stage IV non–small cell lung cancer based on mutational status

Article: TSH Abnormalities and Treatment Algorithms in Primary Care

MD Clip on Diabetes & Urinary ACR: Detecting Kidney Damage Early with Dr Saraogi

Article: A Review on Fluoride Effects on Thyroid Function

Article: How to Diagnose and Differentiate Common Causes of Sudden Vision Loss

Eating ultra processed foods may speed up early signs of Parkinson's disease

Select Specialty

Select Topic

¹⁸F-FDG PET/CT is an early predictor of pathologic tumor response and survival after preoperative radiochemotherapy with bevacizumab in high-risk locally advanced rectal cancer